Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 14.69 as of Sunday, July 26, 2026.
Forward PE Ratio (14.69) = Close Price ($167.02) / Consensus Forward EPS ($11.37)
FORWARD PE RATIO
14.69
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-20.10%
vs the sector median at left
Align Technology, Inc.
Market Cap
$11.96B
Forward PE Ratio
14.69
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Align Technology, Inc. (ALGN) | $11.96B | 14.69 |
| Revvity, Inc. (RVTY)vs › | $12.32B | 21.08 |
| Baxter International Inc. (BAX)vs › | $11.57B | 11.66 |
| Insulet Corp. (PODD)vs › | $11.31B | 25.20 |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 37.23 |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | 20.40 |
| Solventum Corporation (SOLV)vs › | $13.51B | 11.91 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | N/A |
| The Cooper Companies, Inc. (COO)vs › | $13.71B | 15.17 |
Trailing P/E
28.0
reported TTM EPS
Forward P/E
14.7
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $11.37 implies +90.8% EPS growth vs the reported trailing $5.96.
At today's $167.02 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $11.37 | $11.22 – $11.71 | 11 | 14.7x |
| 2027-12-31 | $12.36 | $11.96 – $12.63 | 11 | 13.5x |
| 2028-12-31 | $13.60 | $12.51 – $14.97 | 5 | 12.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
